Read the Beforeitsnews.com story here. Advertise at Before It's News here.
Profile image
By Freedom Bunker
Contributor profile | More stories
Story Views
Now:
Last hour:
Last 24 hours:
Total:

Kimberly-Clark To Acquire Tylenol-Maker Kenvue In Giant $40 Billion Merger

% of readers think this story is Fact. Add your two cents.


Kimberly-Clark To Acquire Tylenol-Maker Kenvue In Giant $40 Billion Merger

Consumer products company Kimberly-Clark Corporation announced it will acquire Tylenol maker Kenvue in a cash-and-stock transaction valued at nearly $49 billion, marking one of the largest consumer health mergers in history. 

Kimberly-Clark revealed in a press release that the deal values Kenvue at 14.3x its latest twelve months (LTM) adjusted EBITDA. In return, Kenvue shareholders will receive $3.50 in cash and .14625 Kimberly-Clark shares per Kenvue share, for a total of about $ 21.01 per share. The deal is valued at $48.7 billion. 

The deal is expected to close in 2H 2026. Upon completion, Kimberly-Clark shareholders will own 54% of the combined company, while Kenvue shareholders will own 46%. Both boards have unanimously approved the acquisition. JPMorgan Chase is providing committed financing for the deal. 

The merger unites two mega consumer-product giants, creating a global health and wellness powerhouse with top brands, including Kleenex, Huggies, Tylenol, Neutrogena, Listerine, and Band-Aid, that reach consumers worldwide

Here’s the justification for the merger:

  • Combines Kimberly-Clark’s commercial execution and digital marketing capabilities with Kenvue’s science-backed innovation and healthcare professional networks.

  • Expands global footprint across key growth categories in personal care and health.

  • Enhanced R&D and quality investments to accelerate product innovation and address evolving consumer health needs.

  • Kimberly-Clark CEO Mike Hsu will continue leading the merged company, supported by senior executives from both firms.

Based on Kimberly-Clark’s current projections, the merger would generate 2025 annual net revenues of about $32 billion and adjusted EBITDA of about $7 billion

All sounds great, but this comes at a time when Tylenol faces political scrutiny via the Trump administration, warning mothers to avoid giving their newborns acetaminophen.

Related:

In markets, Kimberly-Clark shares tumbled 15%, while Kenvue shares jumped 20%. 

The question now is whether government regulators will approve the deal, especially given President Trump’s recent comments surrounding Tylenol.

Tyler Durden Mon, 11/03/2025 – 08:05


Source: https://freedombunker.com/2025/11/03/kimberly-clark-to-acquire-tylenol-maker-kenvue-in-giant-40-billion-merger/


Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world.

Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.

"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.

Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.


LION'S MANE PRODUCT


Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules


Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.



Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.


Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

MOST RECENT
Load more ...

SignUp

Login